The global CBD hemp oil market is experiencing significant growth, driven by increasing awareness of cannabidiol (CBD)-based products, rising healthcare expenditure, and growing demand for alternative therapeutic solutions. The market was valued at more than US$ 950 million in 2017 and was projected to surpass US$ 2.5 billion by 2026, expanding at a compound annual growth rate (CAGR) of over 11% during 2018–2026. Growing interest in managing chronic pain, sleep disorders, stress, and neurological conditions has contributed to the increasing adoption of CBD hemp oil across healthcare and wellness applications.

Rising Demand for CBD Hemp Oil in Healthcare Applications

CBD hemp oil is a plant-derived product containing cannabidiol, a non-intoxicating cannabinoid found in cannabis and hemp plants. It has attracted considerable attention from researchers, healthcare professionals, and consumers because of its potential therapeutic applications. Unlike tetrahydrocannabinol (THC), CBD does not produce the characteristic psychoactive effects associated with cannabis.

Increasing prevalence of chronic conditions, including cancer, diabetes, multiple sclerosis, and neurological disorders, has encouraged interest in CBD-based products. Furthermore, growing awareness of alternative approaches to managing stress, depression, inflammation, and chronic pain is supporting market expansion.

Technological advancements and product innovation are also creating new growth opportunities. CBD hemp oil is increasingly available in different formulations, including tinctures, sprays, capsules, topical applications, and vape products. These developments are improving product accessibility and offering consumers greater flexibility.

Market Segmentation and Emerging Opportunities

Based on product type, the global CBD hemp oil market is segmented into hemp-based and marijuana-based products. The hemp-based segment accounted for a significant revenue share in 2017, supported by increasing availability and growing commercial cultivation of industrial hemp. Meanwhile, the marijuana-based segment was expected to experience considerable growth as medicinal cannabis gained wider acceptance.

By application, the market includes neurological pain management and other therapeutic applications. Growing interest in CBD-based solutions for neurological pain and related conditions is expected to support demand among healthcare providers and individual consumers.

Based on distribution channel, the market is categorized into hospital pharmacies, retail pharmacies, online pharmacies, and other channels. Hospital pharmacies held a dominant market position in 2017, supported by increasing healthcare infrastructure and the growing availability of specialized treatment options. However, online pharmacies are emerging as an important distribution channel due to convenience, expanding e-commerce penetration, and improving consumer access in markets with supportive regulations.

Get Sample PDF Copy: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=39518

Regional Outlook: North America Leads Market Expansion

Geographically, the global CBD hemp oil market covers North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America dominated the global market in 2017, supported by growing awareness of medicinal cannabis, increasing healthcare expenditure, and expanding acceptance of CBD-based products. Regulatory developments and the legalization of cannabis for medicinal or recreational purposes in certain jurisdictions have also contributed to regional market growth.

Asia Pacific is expected to emerge as a promising market, driven by increasing healthcare awareness, expanding pharmaceutical industries, and growing interest in alternative therapies. China held a prominent position in the regional market, while Japan and India offered potential opportunities for future expansion.

Competitive Landscape and Key Market Participants

The global CBD hemp oil market is characterized by the presence of established manufacturers and emerging companies focusing on product innovation, strategic partnerships, cultivation expansion, and geographic diversification.

Major companies operating in the market include ENDOCA, Medical Marijuana, Cannoid, Canopy Growth Corporation, Elixinol Global Limited, Isodiol, NuLeaf Naturals, PharmaHemp, Aphria Inc., and Folium Biosciences.

Strategic collaborations and investments in hemp cultivation are helping manufacturers strengthen their supply chains and improve production capabilities. For instance, in April 2018, Elixinol Global announced an agricultural operations expansion in Colorado, U.S., through its collaboration with Kersey Agricultural Company.

Future Outlook of the CBD Hemp Oil Market

The future of the global CBD hemp oil market will largely depend on regulatory developments, clinical research, product quality standards, and consumer acceptance. Increasing investment in research and development, combined with growing interest in cannabidiol-based pharmaceutical formulations, is expected to create new opportunities for market participants.

However, regulatory uncertainty, inconsistent product standards, and limited clinical evidence for several claimed applications remain important industry challenges. Companies that prioritize product transparency, quality assurance, scientific validation, and regulatory compliance are likely to strengthen their competitive positions.

Overall, increasing demand for plant-based wellness products and continued advancements in cannabinoid research are expected to support the long-term development of the global CBD hemp oil market.

Media Contact:
Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453